CORZ
The table below shows Core Scientific, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $278.25M | $42.90M | $65.11M | $205.19M | -$56.73M | -$23.77M |
| Capital expenditure | $729.00M | $94.96M | $16.16M | $383.98M | $0.00 | $0.00 |
| Investing cash flow | -$740.75M | -$95.19M | -$3.00M | -$590.78M | -$423.84M | -$15.14M |
| Dividends paid | - | - | - | - | - |
Core Scientific, Inc. reported operating cash flow of $278.25M for fiscal year 2025. That is up 548.7% from $42.90M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow grew from -$23.77M (FY 2020) to $278.25M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | $0.00 | $0.00 | $31.65M | - | - |
| Financing cash flow | -$63.10M | $819.57M | -$44.65M | $306.15M | $603.53M | $40.72M |